List of Tables
    Table 1. Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Oncology Therapeutic Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Oncology Therapeutic Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Oncology Therapeutic Drug Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Oncology Therapeutic Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Oncology Therapeutic Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Oncology Therapeutic Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Oncology Therapeutic Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Oncology Therapeutic Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Oncology Therapeutic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Therapeutic Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)
    Table 16. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Oncology Therapeutic Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
    Table 20. North America Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Oncology Therapeutic Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
    Table 40. Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Oncology Therapeutic Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Oncology Therapeutic Drug Revenue Share by Type (2017-2022)
    Table 43. Global Oncology Therapeutic Drug Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Oncology Therapeutic Drug Sales (K Units) by Application (2017-2022)
    Table 45. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Oncology Therapeutic Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Oncology Therapeutic Drug Revenue Share by Application (2017-2022)
    Table 48. Global Oncology Therapeutic Drug Price by Application (2017-2022) & (US$/Unit)
    Table 49. AbbVie Corporation Information
    Table 50. AbbVie Description and Business Overview
    Table 51. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. AbbVie Oncology Therapeutic Drug Product
    Table 53. AbbVie Recent Developments/Updates
    Table 54. Amgen Corporation Information
    Table 55. Amgen Description and Business Overview
    Table 56. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Amgen Oncology Therapeutic Drug Product
    Table 58. Amgen Recent Developments/Updates
    Table 59. Astellas Pharma Corporation Information
    Table 60. Astellas Pharma Description and Business Overview
    Table 61. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Astellas Pharma Oncology Therapeutic Drug Product
    Table 63. Astellas Pharma Recent Developments/Updates
    Table 64. AstraZeneca Corporation Information
    Table 65. AstraZeneca Description and Business Overview
    Table 66. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. AstraZeneca Oncology Therapeutic Drug Product
    Table 68. AstraZeneca Recent Developments/Updates
    Table 69. Bayer Corporation Information
    Table 70. Bayer Description and Business Overview
    Table 71. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Bayer Oncology Therapeutic Drug Product
    Table 73. Bayer Recent Developments/Updates
    Table 74. Biogen Corporation Information
    Table 75. Biogen Description and Business Overview
    Table 76. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Biogen Oncology Therapeutic Drug Product
    Table 78. Biogen Recent Developments/Updates
    Table 79. Bristol Myers Squibb Corporation Information
    Table 80. Bristol Myers Squibb Description and Business Overview
    Table 81. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Bristol Myers Squibb Oncology Therapeutic Drug Product
    Table 83. Bristol Myers Squibb Recent Developments/Updates
    Table 84. Celgene Corporation Information
    Table 85. Celgene Description and Business Overview
    Table 86. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Celgene Oncology Therapeutic Drug Product
    Table 88. Celgene Recent Developments/Updates
    Table 89. Eisai Corporation Information
    Table 90. Eisai Description and Business Overview
    Table 91. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Eisai Oncology Therapeutic Drug Product
    Table 93. Eisai Recent Developments/Updates
    Table 94. Eli Lilly and Company Corporation Information
    Table 95. Eli Lilly and Company Description and Business Overview
    Table 96. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Eli Lilly and Company Oncology Therapeutic Drug Product
    Table 98. Eli Lilly and Company Recent Developments/Updates
    Table 99. Gilead Sciences Corporation Information
    Table 100. Gilead Sciences Description and Business Overview
    Table 101. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Gilead Sciences Oncology Therapeutic Drug Product
    Table 103. Gilead Sciences Recent Developments/Updates
    Table 104. Ipsen Corporation Information
    Table 105. Ipsen Description and Business Overview
    Table 106. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Ipsen Oncology Therapeutic Drug Product
    Table 108. Ipsen Recent Developments/Updates
    Table 109. Johnson and Johnson Corporation Information
    Table 110. Johnson and Johnson Description and Business Overview
    Table 111. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Johnson and Johnson Oncology Therapeutic Drug Product
    Table 113. Johnson and Johnson Recent Developments/Updates
    Table 114. Merck Corporation Information
    Table 115. Merck Description and Business Overview
    Table 116. Merck Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Merck Oncology Therapeutic Drug Product
    Table 118. Merck Recent Developments/Updates
    Table 119. Novartis Corporation Information
    Table 120. Novartis Description and Business Overview
    Table 121. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Novartis Oncology Therapeutic Drug Product
    Table 123. Novartis Recent Developments/Updates
    Table 124. Otsuka Pharmaceutical Corporation Information
    Table 125. Otsuka Pharmaceutical Description and Business Overview
    Table 126. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Otsuka Pharmaceutical Oncology Therapeutic Drug Product
    Table 128. Otsuka Pharmaceutical Recent Developments/Updates
    Table 129. Pfizer Corporation Information
    Table 130. Pfizer Description and Business Overview
    Table 131. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Pfizer Oncology Therapeutic Drug Product
    Table 133. Pfizer Recent Developments/Updates
    Table 134. F. Hoffmann-La Roche Corporation Information
    Table 135. F. Hoffmann-La Roche Description and Business Overview
    Table 136. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. F. Hoffmann-La Roche Oncology Therapeutic Drug Product
    Table 138. F. Hoffmann-La Roche Recent Developments/Updates
    Table 139. Sanofi Corporation Information
    Table 140. Sanofi Description and Business Overview
    Table 141. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. Sanofi Oncology Therapeutic Drug Product
    Table 143. Sanofi Recent Developments/Updates
    Table 144. Takeda Pharmaceutical Corporation Information
    Table 145. Takeda Pharmaceutical Description and Business Overview
    Table 146. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Takeda Pharmaceutical Oncology Therapeutic Drug Product
    Table 148. Takeda Pharmaceutical Recent Developments/Updates
    Table 149. Teva Pharmaceutical Industries Corporation Information
    Table 150. Teva Pharmaceutical Industries Description and Business Overview
    Table 151. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 152. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product
    Table 153. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 154. Production Base and Market Concentration Rate of Raw Material
    Table 155. Key Suppliers of Raw Materials
    Table 156. Oncology Therapeutic Drug Distributors List
    Table 157. Oncology Therapeutic Drug Customers List
    Table 158. Oncology Therapeutic Drug Market Trends
    Table 159. Oncology Therapeutic Drug Market Drivers
    Table 160. Oncology Therapeutic Drug Market Challenges
    Table 161. Oncology Therapeutic Drug Market Restraints
    Table 162. Global Oncology Therapeutic Drug Sales Forecast by Type (2023-2028) & (K Units)
    Table 163. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2023-2028)
    Table 164. Global Oncology Therapeutic Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 165. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 166. Global Oncology Therapeutic Drug Sales Forecast by Application (2023-2028) & (K Units)
    Table 167. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2023-2028)
    Table 168. Global Oncology Therapeutic Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 169. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 170. Global Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)
    Table 171. Global Oncology Therapeutic Drug Sales Market Share Forecast by Region (2023-2028)
    Table 172. Global Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 173. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oncology Therapeutic Drug
    Figure 2. Global Oncology Therapeutic Drug Market Share by Type in 2021 & 2028
    Figure 3. Chemotherapy Product Picture
    Figure 4. Targeted Therapy Product Picture
    Figure 5. Immunotherapy Product Picture
    Figure 6. Hormonal Therapy Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Oncology Therapeutic Drug Market Share by Application in 2021 & 2028
    Figure 9. Breast Cancer
    Figure 10. Gastrointestinal Cancer
    Figure 11. Prostate Cancer
    Figure 12. Respiratory and Lung Cancer
    Figure 13. Others
    Figure 14. Global Oncology Therapeutic Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Oncology Therapeutic Drug Market Size (2017-2028) & (US$ Million)
    Figure 16. Global Oncology Therapeutic Drug Sales (2017-2028) & (K Units)
    Figure 17. Oncology Therapeutic Drug Sales Share by Manufacturers in 2021
    Figure 18. Global Oncology Therapeutic Drug Revenue Share by Manufacturers in 2021
    Figure 19. The Global 5 and 10 Largest Oncology Therapeutic Drug Players: Market Share by Revenue in 2021
    Figure 20. Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
    Figure 22. Global Oncology Therapeutic Drug Sales Market Share by Region in 2021
    Figure 23. Global Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
    Figure 24. Global Oncology Therapeutic Drug Revenue Market Share by Region in 2021
    Figure 25. United States Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Canada Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Germany Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. France Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. U.K. Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Italy Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Russia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Japan Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. South Korea Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. India Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Australia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. China Taiwan Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Indonesia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Thailand Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Malaysia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Colombia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. UAE Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Oncology Therapeutic Drug by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Oncology Therapeutic Drug
    Figure 50. Manufacturing Process Analysis of Oncology Therapeutic Drug
    Figure 51. Oncology Therapeutic Drug Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed